RA

Robert Alonso

MP Mitochon Pharmaceuticals: 7 patents #1 of 5Top 20%
AP Actelion Pharmaceuticals: 2 patents #74 of 188Top 40%
BI Bioventures: 2 patents #37 of 141Top 30%
Overall (All Time): #251,731 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11833161 Compositions and methods for treatment of skin infections Lawrence Stoll 2023-12-05
11717497 Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases John Gerard Geisler 2023-08-08
11504384 Compositions and methods for treatment of skin infections Lawrence Stoll 2022-11-22
11406642 DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases John Gerard Geisler, Peter A. Crooks, Narsimha Reddy Penthala, Zaineb Albayati 2022-08-09
10864173 Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases John Gerard Geisler 2020-12-15
10744174 Composition(s) and method(s) for topically treating pain Lawrence Stoll 2020-08-18
10548900 DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases John Gerard Geisler, Peter A. Crooks, Narsimha Reddy Penthala, Zaineb Albayati 2020-02-04
10220006 Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases John Gerard Geisler 2019-03-05
9974755 Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases John Gerard Geisler 2018-05-22
9763896 Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases John Gerard Geisler 2017-09-19
9382191 Stabilized compositions of volatile alkylating agents and methods of using thereof Peter A. Crooks, Mark A. Pimley 2016-07-05
8664278 Stabilized compositions of volatile alkylating agents and methods of using thereof Peter A. Crooks, Mark A. Pimley 2014-03-04
8501818 Stabilized compositions of alkylating agents and methods of using same Martin Stogniew, Peter A. Crooks, Mark A. Pimley, David R. Worthen 2013-08-06
8501817 Stabilized compositions of alkylating agents and methods of using same Barry Walker, Peter A. Crooks 2013-08-06
8501819 Stabilized compositions of volatile alkylating agents and methods of using thereof Peter A. Crooks, Mark A. Pimley 2013-08-06
8450375 Stabilized compositions of volatile alkylating agents and methods of using thereof Peter A. Crooks, Mark A. Pimley, Abeer M. Al-Ghananeem 2013-05-28
7872050 Stabilized compositions of volatile alkylating agents and methods of using thereof Peter A. Crooks, Mark A. Pimley 2011-01-18
7838564 Stabilized compositions of volatile alkylating agents and methods of using thereof Peter A. Crooks, Mark A. Pimley, Abeer M. Al-Ghananeem 2010-11-23